Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinggong Granules in Qi Stagnation and Blood Stasis Uterine Fibroids
CTR20150274Phase 2Active
- Sponsor
- Fuzhou Changfuxing New Drug Development
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Jinggong Granules in Fibromyoma (LM), sponsored by Fuzhou Changfuxing New Drug Development. Started Apr 2015; status: active.
02
Drugs
Jinggong Granules
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on CTR20150274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150274.